Biopharmaceutical company focused on bringing novel therapeutics to address large unmet medical needs for the Japanese healthcare market. Company is privately held and backed by CBC Group (formerly C-Bridge Capital), one of the largest healthcare investment funds with $4.5B+ AUM.
Employees
1-10This company has no teams yet
This company has no offices yet